Objective: Haplotype-specific alternative splicing of the endoplasmic reticulum (ER) aminopeptidase type 2 (ERAP2) gene results in either full-length (FL, haplotype A) or alternatively spliced (AS, haplotype B) mRNA. As ERAP2 trims peptides loaded on major histocompatibility complex (MHC) class I and CD8 þ T lymphocytes protect against viral infections, we analysed its role in resistance to HIV-1 infection.
Introduction
CD8 þ T cells recognize targets through interaction between their T-cell receptor and a binary complex formed by a major histocompatibility complex (MHC) class I molecule associated with a peptide produced by the degradation of intracellular proteins [1, 2] . This process allows CD8 þ T lymphocytes to identify and eliminate cells that are synthesizing abnormal or foreign proteins as may arise through mutations or viral infections. The composition of the peptide repertoire presented by the MHC I depends on the specificity of the MHC peptidebinding groove, but also on the availability of peptides generated by the antigen-processing pathway that can fit in such groove.
The processing of intracellular proteins is a multistep event beginning in the cytoplasm where the proteasome fragments intracellular proteins to cut them at the precise C-terminus of the final peptide and generates a mixture of N-terminally extended intermediates [3] . These peptides are then transported into the endoplasmic reticulum (ER) where the ER aminopeptidase 1 and 2 (ERAP1 and ERAP2) trim the N-terminal residues to generate the correct length peptides, which are subsequently bound by MHC class I molecules and presented on the cell surface [3] .
Interestingly, studies in Erap1À/À mice show that this enzyme shapes the peptide repertoire presented by MHC I molecules in normal and virus-infected cells [4, 5] . Recent data supporting this observation show that cytomegalovirus manages to avoid cytotoxic T lymphocytes (CTL)-mediated immune responses by expressing a micro-RNA that specifically targets ERAP1, inhibiting the trimming of precursors to generate mature epitopes [6] .
Both ERAP1 and ERAP2 have been targets of a longstanding balancing selection [7, 8] . In particular, this process has maintained two highly differentiated ERAP2 haplotypes at intermediate frequency in most human populations [7, 8] . The two haplotypes, hereafter referred to HapA and HapB, differ at multiple variants in tight linkage disequilibrium. HapB harbours the T allele for rs2549782 (Asn392Lys) and the G allele for rs2248374; this latter has been shown to determine the activation of a cryptic splice site in intron 10 and the production of an alternatively spliced ERAP2 mRNA (ERAP2-AS) with an in-frame stop codon [8, 9] . Thus, the predicted protein product of HapB-derived transcripts is a truncated protein of 534 amino acids, whereas the canonical ERAP2 protein, consisting of 960 amino acids, is encoded by a full-length mRNA (ERAP2-FL) transcribed from HapA.
Recently the G allele of rs2549782, which tags HapA, was found to be significantly overrepresented in HIV-1-exposed seronegative individuals (HESNs), indicating that association between rs2549782 and HIV-1 protection follows a recessive model [7] .
Based on this observation we extended the analyses of the possible role of ERAP2 in the modulation of resistance to HIV infection by verifying whether diverse ERAP2 alleles differently modulate antigen processing and presentation.
Materials and methods

Study population
We recruited 104 white men exposed to HIV-1 infection by IDU from a Spanish cohort (Valme Hospital, Seville, Spain) whose epidemiological and clinical characteristics were described previously [10] . A group of 130 HIV-1 and HCV-seronegative healthy white men blood donors from the Jaen Hospital was used as healthy controls.
The study was designed and performed according to the Helsinki declaration and was approved by the ethics committee of the participating units. All participants provided written informed consent to participate in this study.
Similarly, informed consent was obtained from 139 HIV-1 and HCV-seronegative Italian healthy controls. Whole blood was collected from all participants, and DNA was extracted by phenol chloroform method (Promega, Madison, Wisconsin, USA). As for Italian sexually HESN, inclusion criteria are described in [7] .
Genotyping
Genomic DNA was used as template for PCR amplification using TaqMan probes specifically designed to perform a SNP genotyping assay for rs2549782 (G/T) (TaqMan SNP Genotyping Assay; Applied Biosystems, Foster City, California, USA) and using the allelic discrimination real-time PCR method. The polymorphic 32 bp deletion at the CCR5 locus was typed by PCR using specific primers (forward: 5 0 -TGGTGGCTGTGTTTGCGTCT-3 0 ; reverse: 5 0 -ATGACAAGCAGCGGCAGGAC-3 0 ). The PCR products were electrophoretically separated on 3% agarose gels.
Human leukocyte antigen typing
Human leukocyte antigen (HLA) typing of class-I HLA-B locus was performed by single specific primerspolymerase chain reaction method using Histo-Type DNA plates (BAG Healthcare, Formedic s.r.l., Milan, Italy). Detection of the alleles recognized by the specific primers was possible after amplification in a GeneAmp PCR 9700 thermocycler (Applied Biosystems) and gel electrophoresis on 2% agarose gel.
HIV infections assay
Peripheral blood mononuclear cell (PBMC) were separated by whole blood on lymphocyte separation medium (Organon Teknica, West Chester, Pennsylvania, USA), and CD4 þ cells isolated with the CD4 þ Isolation Kit (Miltenyi Biotech Gladbach, Germany) were in-vitro infected as previously described [11] . After 5 days supernatants were collected for p24 antigen ELISA (PerkinElmer Waltham, Massachusetts, USA) and MHC I analyses, whereas PBMC collected at 3 days were used for RNA extraction.
Real-time PCR cDNA quantification for ERAP2-FL, ERAP2-AS, interferon (IFN)-g, transporter associated with antigen processing 1 (TAP1) and Glyceraldehyde 3-phosphate dehydrogenase was performed by real-time PCR as described elsewhere [11] . We also designed primers that do not discriminate ERAP2-FL from ERAP2-AS, to quantify the total content of ERAP2 (ERAP2-Tot). Primer sequences are reported in supplementary methods (Table S1, http://links.lww.com/QAD/A327).
Antigen presentation pathway
Antigen presentation pathway was analysed in a PCR array including a set of optimized real-time PCR primers on 96-well plates (LONZA, Basel, Switzerland) (Supplemental Material, http://links.lww.com/QAD/A327). The experiments have been run on 139 Italian healthy controls pooled into three distinct homoA, homoB and heteroAB groups. Thus, the results represent the mean value of the different targets analysed in homoA, homoB and heteroAB groups.
Human leukocyte antigen expression on CD45 R cell surface Flow cytometric analysis was performed 5 days after invitro HIV-1 infection staining 5 Â 10 5 PBMCs for 15 min with fluorescent directly labelled surface antibodies: CD45pecy5 and HLA-ABC FITC (Beckman Coulter, Brea, California, USA). Cells stained with the appropriate isotype-matched immunoglobulin (Ig) were used as negative controls. After staining, cells were fixed in 1% paraformaldehyde (PFA; Sigma-Aldrich). HLA-ABC expression was evaluated as mean fluorescence intensity (MFI) on leukocytes gated by CD45 þ cells. Analyses were carried out blindly with respect to genotypes. Cytometric analysis was performed on 200 000 CD45 events using a FC500 flow cytometer (Beckman-Coulter). Green florescence from FITC (FL1) was collected through a 525-nm band pass filter and deep-red fluorescence from Cy5PE (FL4) was collected through a 670-nm band-pass filter using linear amplifiers for forward and side scatter and logarithmic amplifiers for FL1 and FL4. Flow data were analysed by first gating on the leukocyte population as defined by forward and side light scatters and then on CD45 expression.
Western blot analyses
Western blot analyses were performed as previously described [12] . Proteins were detected using a 1 : 5000 dilution of primary antibody [goat anti-ERAP2 polyclonal antibody (AF3830; R&D Systems, Minneapolis, Minnesota, USA), anti-b-actin monoclonal prepared in mouse (A5316; Sigma, Saint Louis, Missouri, USA)] and a 1 : 10 000 dilution of secondary antibody conjugated with alkaline phosphatase [goat antimouse Immunoglobulin G (IgG) (sc-2005; Santa Cruz Biotechnology Dallas, Texas, USA) and antigoat IgG (A4187; Sigma]. Proteins were then visualized by treatment with Sigmafast BCIP/NBT for 5 min (B5556; Sigma).
Cloning, plasmid construction and transfection
The cDNA of ERAP2 was PCR amplified using highfidelity polymerase (Pfu DNA Polymerase; Promega) from both hapA and hapB homozygous cell lines. The two products were checked by direct sequencing and cloned in the cell-free pF3A WG(BYDV) expression vector (Promega).
Statistical analyses
Statistical analyses were performed using SPSS Statistical Package for the Social Sciences (version 11; SPSS Inc., Chicago, Illinois, USA). Differences between the groups were assessed using nonparametric analyses (Mann-Whitney U test). All P values are two-tailed. For metaanalysis a random-effects model as implemented in PLINK [13] was applied.
Results
Genetic association with HIV-1 infection susceptibility
The rs2549782 variant tags the two major ERAP2 haplotypes, with the G-allele defining hapA (rs2549782G[392Lys]-rs2248374A[canonical splice site]) and the T-allele defining hapB (rs2549782T[392Asn]-rs2248374G[alternative splice site]). Thus, according to genotyping, participants were determined to be HapA/ HapA homozygotes (homoA), HapB/HapB homozygotes (homoB) or HapA/HapB heterozygotes (het-eroAB). Results showed that the frequency of homoA was 26 and 14% in IDU-HESN and healthy controls, respectively. Logistic regression indicated that the difference is statistically significant, and the odds ratio for a recessive model with homoA being protected from HIV-1 infection is 0.50 [95% confidence interval (95% CI) 0.26-0.97, P ¼ 0.0392) (Table 1) [7] . The frequency of the CCR5D32 allele is higher in IDU-HESN (0.102) than in healthy controls (0.052), but inclusion of genotype status at CCR5 as a covariate in the logistic regression did not affect the association with rs2549782 (P ¼ 0.0391).
To perform a meta-analysis we used data from the previously published study [7] . We applied a randomeffects model [14] and obtained a P value of 9.6 Â 10 -5 [odds ratio (OR) ¼ 0.41] ( Table 1 ). These results confirm that the rs2549782 ERAP2 variant is associated with protection against HIV infection and show how this effect is independent on the route of exposure.
Human leukocyte antigen-B typing and co-occurrence analysis
The HLA-B Ã 57 allele has previously been associated with protection from HIV-1 infection [15, 16] . To verify whether ERAP2 haplotype status interacts with HLA-B Ã 57, we genotyped rs2549782 and performed a co-occurrence analysis in Italian sexually exposed HESN and HIV-positive participants. Results showed that 32% of homoA HESN are also HLA-B Ã 57 positive, compared with only 6% of nonhomoA participants (P ¼ 0.011), indicating that the HESN phenotype is associated with the co-presence of the HLA-B Ã 57 allele and the homoA status at ERAP2. The same situation is not observed among HIV-positive individuals, as the percentage of homoA and nonhomoA individuals carrying the HLA-B Ã 57 is not significantly different (P ¼ 0.14) ( Table 2) .
Endoplasmic reticulum aminopeptidase 2 mRNA basal expression PBMC of 139 Italian healthy controls were genotyped for rs2549782; results showed that HapA and B were equally represented, mirroring the allele frequency reported for major human populations [7, 8] .
ERAP2-FL mRNA levels were significantly higher in homoA compared to heteroAB cells (P ¼ 0.04). Unexpectedly, marginal levels of ERAP2-FL mRNA were also detected in homoB PBMC, although were significantly lower compared with those observed either in homoA (P ¼ 0.00031) or in heteroAB (P ¼ 0.006) cells ( Fig. 1a ).
ERAP2-AS mRNA was found in homoB and, even though in limited quantities, in heteroAB cells (P ¼ 0.0004), whereas it was completely absent in homoA PBMC (Fig. 1b ).
Finally, high, intermediate and low levels of ERAP2-Tot expressions were seen in homoA, heteroAB and homoB samples, respectively (Fig. 1c ). These differences were statistically significant (P < 0.05 in both cases), suggesting that participants with different ERAP2 genotype do express diverse quantities of ERAP2 to shape their antigen repertoire.
Susceptibility to HIV infection
To verify whether ERAP2 genotype influences susceptibility to HIV infection in vitro, PBMCs isolated from the 139 Italian healthy controls (35 homoA, 64 heteroAB and 40 homoB) were in-vitro infected with HIV-1. Five days after infection p24 levels in PBMC cultures were significantly lower in homoA compared with both homoB (P ¼ 7 Â 10 À4 ) and heteroAB samples (P ¼ 2.94 Â 10 À5 ) (Fig. 1d ). These results are consistent with the previously suggested recessive model of HIV-1 1700 AIDS 2013, Vol 27 No 11 protection conferred by HapA [7] , and with the genetic association analysis in the IDU-HESN cohort (Table 1) .
Conversely, p24 levels in CD4 þ cell cultures isolated from 42 healthy controls (7 homoA, 23 heteroAB, and 12 homoB) were comparable in the three genotypic group, suggesting a role for CD8 þ cells in resistance to HIV-1 infection in homoA participants (Fig. 1e ).
Analyses of endoplasmic reticulum aminopeptidase 2-full-length, interferon-g and Transporter associated with antigen processing 1 mRNA expression Following 3 days of in-vitro HIV infection, a significantly higher transcription rate was observed for ERAP2-FL, IFN-g and TAP1 in homoA compared with both homoB and heteroAB cells (P < 0.05 for all comparisons) ( Fig. 2a) .
Notably, ERAP2-FL, TAP1 and IFN-g mRNA expression were inversely correlated to p24 concentration, suggesting a possible association between the expression of these genes and susceptibility to HIV-1 infection.
Antigen processing and presentation pathway genes mRNA expression
To determine whether the differences observed for ERAP2-FL, TAP1 and IFN-g expression in cells of individuals with different ERAP2 genotypes could be extended to other factors involved in the antigen processing and presentation pathway, we used a realtime PCR array, which screens for the expression of 96 genes implicated in that process.
Data obtained by real-time PCR array 3 days after in-vitro HIV infection (Fig. 2b) show a generalized and significant increase of a great number of the genes involved in nearly all aspects of antigen processing and presentation pathway in homoA compared with both homoB and heteroAB cells.
Effect of endoplasmic reticulum aminopeptidase 2 variants on major histocompatibility complex class I expression
As the transient knockdown of ERAP1 and ERAP2 was correlated to a reduced level of MHC class I molecules expression [17] , we analysed HLA-A, B and C MFIs on CD45 þ leukocytes from 139 healthy controls with different genotype. Results showed that MHC class I (HLA-A, B, C) MFIs were significantly reduced in heteroAB and homoB compared with homoA cells both in basal conditions and upon HIV-1 infection (P < 0.05 in all conditions) ( Fig. 3) . Notably, such a difference was not seen with CD45, a marker constitutively expressed by leukocytes (data not shown). These results demonstrate that the presence of the ERAP2 HapB correlates with reduced levels of MHC class I expression on leukocyte surfaces.
Endoplasmic reticulum aminopeptidase 2 protein expression
To verify whether the mRNA derived from the fulllength and alternative spliced form of ERAP2 are both translated into functional proteins, we performed a western blot analyses on PBMCs isolated from 15 Italian healthy controls (five homoA, five heteroAB and five homoB). The recombinant full-length and truncated proteins were also loaded. Results showed that homoA and heteroAB PBMCs produce only full-length ERAP2 (120 kDa), whereas no detectable ERAP2 protein was found in cells isolated from homoB participants. Notably, the intensity of the full-length ERAP2 band in heteroAB participants was lower of the one detected in homoA participants. Conversely, the truncated ERAP2 protein (62 kDa) could not be detected in any of the analysed participants, independently of their ERAP2 genotype (Fig. 4 ).
Discussion
The repertoire of peptides presented by MHC I molecules on cell membranes is shaped by the aminopeptidases located in the ER, also known as ERAPs. In line with their central role in antigen ABCB9  B2M  CALR  CTSE  CTSL2  CD209  CD40  CD46  CD74  CD86  CDC42  HSPA5  HSP90AB1  HFE  ICOS  IRF2  IRF8 LGMN processing, variants in ERAP1 and ERAP2 have been associated with ankylosing spondylitis [18, 19] , Crohn's disease [20] , and multiple sclerosis [21] , and a variant that tags HapA (rs2549782-G) in ERAP2 was shown to protect from sexually transmitted HIV-1 infection [7] . Data herein replicate the association between the ERAP2 polymorphism and HIV-1 protection in an independent cohort of participants with different geographic origin and a diverse infection exposure route. Meta-analysis of the results obtained in the two cohorts provided strong support to the association between diplotype status at ERAP2 and natural resistance to HIV-1 infection.
In the attempt to explain this effect we performed analyses on cells of healthy individuals who were genotyped for their ERAP2 gene. Results of infection assays with HIV-1 Ba-L showed that PBMC from homoA participants allow lower viral replication compared with cells derived from both heteroAB and homoB participants. This effect may at least partially be mediated by different ERAP2 expression levels in participants with diverse ERAP2 genotype. Supporting this possibility, results herein indicate that both in basal condition and following invitro HIV-1 infection, the transcript level for ERAP2-FL and ERAP2-Tot was significantly higher in homoA compared with heteroAB and barely detectable in homoB cells. These data are in line with previous observations [8] and with western blot results, suggesting that ERAP2 diplotype status determines the abundance of the full-length protein product of ERAP2, which, in turn, might shape the antigen repertoire available for CD8 þ T-cell clone stimulation. The relationship correlating ERAP2 genotype to ERAP2 quantity, antigen presentation and CD8 þ cells activation is strengthened by the observation that HIV-1 infection assay performed in the absence of CD8 þ cells did not show differences in susceptibility among the three genotype groups.
In accordance with these observations, different groups independently generated endoplasmic recticulum aminopeptidase associated with antigen processing (ERAAP)-deficient mice and established that trimming of antigenic peptides by ERAAP in the ER is critical for generating a standard peptide-MHC class I repertoire [4, [22] [23] [24] [25] as, in the absence of ERAAP, the overall expression of cell surface classical and nonclassical MHC I molecules is reduced. In agreement with these results, we demonstrate that reduction of ERAP2-FL levels results in a quantitative diminution of MHC class I expression on CD45 þ cells both in uninfected and HIV-1 infected cell cultures.
Following HIV-infection, not only ERAP2-FL but also a number of genes directly involved in the antigen processing and presentation pathway are expressed at higher levels in homoA cells. The genes whose mRNA was upregulated in homoA cells are implicated in almost all phases of antigen processing and presentation, including the regulation and enhancement of class I and class II expression (TAP1, ABCB9, B2M, CALR,  CD74, CTSE, CTSL2, HSPA5, HSP90AB1, HFE,  IRF2, IRF8, LGMN, HLA-A, HLA-B, HLA-G, HLA-DQB2, HLA-DRA, PML, RFXANK, TAPBP), the proteasome system (PSME2), antigen presentation costimulation (CD40, CD46, ICOS, PRKCD, STAT1), lysosomal proteases (LGMN), as well as antigen uptake by antigen presenting cells (CD209, CDC42) and aminopeptidases (NPEPPS). It is possible to speculate that in the presence of a wider or more stable peptide repertoire generated by ERAP2 homoA cells all the factors involved in the presentation of the antigen are boosted, contributing to the activation of an optimal immune response.
Data herein show that heteroAB individuals display a phenotype that was very similar to that of homoB individuals, supporting the previously suggested recessive model for HIV-1 protection conferred by HapA [7] , and suggesting that chromosomes carrying HapB could encode a product with dominant negative effect. However, accordingly with the very low expression of ERAP2-Tot seen in homoB individuals, we were unable to detect any signal for the truncated protein. These data corroborate the assumption that ERAP2-AS mRNA undergoes a nonsense-mediated decay [8] , but do not explain why heteroAB participants display the same phenotype as homoB. There are several possible explanations for this observation. First, the amount of truncated protein might be under the sensitivity threshold of the technique, but could still exert a dominant negative effect. In fact, recently, Evnouchidou et al. [26] established that ERAP2 SNP rs2549782, associated to HapB leads to a substrate-specific changes in enzymatic activity, allowing the enzyme to alter its specificity profile for peptidic substrate. Second, the amount of full-length ERAP2 protein might be ratelimiting for efficient antigen presentation, so that a decrease in the overall available protein is sufficient to produce an immunological response to HIV-1 infection that is scarcely protective. Third, alterations in ERAP2 availability might affect the stoichiometry of ERAP1/ ERAP2 heterodimers formation. Indeed, the two aminopeptidases are known to physically interact, although the precise fraction of ERAP1 and ERAP2, which is engaged in complex formation, is unknown [17] . The trimming specificity of heterodimers and homodimers remains to be evaluated, but can reasonably be thought to differ, allowing the trimming of a wider range of antigenic peptides. Lower levels of ERAP2 protein might thus alter the relative abundance of homodimers and heterodimers and, as a consequence, the final repertoire of MHC I available cargos. This in turn might be relevant to the specificity of CD8 þ T cells, as suggested with ERAAP-deficient mice [4, [22] [23] [24] [25] .
It was previously reported that, in the presence of the same MHC class I alleles, CD8 þ T cells from HESN recognize unusual peptides that may confer resistance to HIV-1 infection [27] . It is thus tempting to speculate that the homoA status at ERAP2, which is prevalent in HESN, is capable to shape a peptide repertoire that activates a biologically more advantageous pool of CD8 þ T cells. Indeed, the role of ERAP1 and ERAP2 in antigen processing and presentation suggests that variants in these genes might also interact with specific HLA class I alleles to modulate distinct phenotypes. For example, polymorphisms in ERAP1 predispose to ankylosing spondylitis and psoriasis depending on the allelic status at HLA-B and HLA-C, respectively [28, 29] . A systematic analysis of genetic interaction with HLA alleles requires extremely large sample sizes, due to the high allelic diversity at these loci. Thus, we focused on HLA-B Ã 57, which has been associated with both delayed progression to AIDS and decreased HIV infection susceptibility [15, 16] . Data herein indicate that, in HESN, the HLA-B Ã 57 alleles is much more common than expected among homoA participants, suggesting synergy in protecting from infection. Whether additional HLA alleles interact with ERAP2 genotypes remains to be evaluated, but is a likely possibility as multiple alleles, as well as specific aminoacid residues in HLA-B and HLA-C, are known to control HIV viral load [30] .
Finally, it will be interesting to clarify whether the HapAassociated protective effect is specific for HIV-1 infection or if it is applicable to other pathogens. Remarkably Draenert et al. [31] demonstrated that HIV-1 evolved a strategy to avoid ERAP1 trimming, underling the key role played by aminopeptidases in the shaping of HIV-1 antigen repertoire and suggesting that, despite the high redundancy of peptides offered by MHC class I, epitope specificity controls immune response. Further, cytomegaloviruses are endowed with a miRNA-based CTLevasion mechanism that specifically targets ERAP1, inhibiting the trimming of precursors to HLA class I-presented mature epitopes [6] . Different alleles in ERAP proteins are thus likely to determine the differential processing of peptides originated from intracellular pathogens, resulting in a unique repertoire of antigens presented to CD8 þ T cells and in a diverse vulnerability to infections.
To summarize, ERAP2 diplotype status is associated with resistance to HIV-infection; this effect is probably secondary to the modulation of the antigen processing/presenting machinery, resulting in quantitative and possibly qualitative changes in MHC class I complexes on target cells. Further studies will be necessary to verify whether genetic variations in ERAP2 influence the epitope repertoire and to establish whether these variations play a role in determining susceptibility to other intracellular pathogen infections.
